Burleson & Company, LLC Avanos Medical, Inc. Transaction History
Burleson & Company, LLC
- $384 Million
- Q4 2022
A detailed history of Burleson & Company, LLC transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Burleson & Company, LLC holds 125 shares of AVNS stock, worth $2,002. This represents 0.0% of its overall portfolio holdings.
Number of Shares
125
Previous 125
-0.0%
Holding current value
$2,002
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AVNS
# of Institutions
274Shares Held
42.2MCall Options Held
5.4KPut Options Held
5K-
Black Rock Inc. New York, NY7.01MShares$112 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.32MShares$85.2 Million0.0% of portfolio
-
Rgm Capital, LLC Naples, FL3.17MShares$50.8 Million3.28% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.59MShares$41.5 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.37MShares$37.9 Million0.03% of portfolio
About AVANOS MEDICAL, INC.
- Ticker AVNS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 46,487,000
- Market Cap $745M
- Description
- Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...